Endoscopic treatment of fibro-adipose vascular anomaly
10.3760/cma.j.cn114453-20240419-00100
- VernacularTitle:纤维脂肪血管性病变的腔镜手术治疗效果
- Author:
Peihua WANG
1
;
Chong XIE
1
;
Huaijie WANG
1
;
Zhengtuan GUO
1
;
Weilong LIN
1
;
Weijia YANG
1
Author Information
1. 西安国际医学中心医院小儿外科与脉管异常中心，西安 710100
- Publication Type:Journal Article
- Keywords:
Hemangioma;
Vascular malformations;
Fibro-adipose vascular anomaly;
Endoscopic;
Surgical procedures
- From:
Chinese Journal of Plastic Surgery
2025;41(7):699-704
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the feasibility and safety of endoscopic surgery in the treatment of fibro-adipose vascular anomaly (FAVA).Methods:Clinical data of FAVA patients who underwent endoscopic treatment admitted to Xi’an International Medical Center Hospital from October 1, 2019 to April 1, 2024 were retrospectively analyzed, including gender, age of onset, age of diagnosis, lesion location, operation time, intraoperative blood loss, hospital stays, incision complications, etc. Before endoscopy, magnetic resonance imaging and ultrasound were routinely used to locate the lesion range, and the surgical position and Trocar location were selected according to different lesion sites.Descriptive statistical analysis was conducted using SPSS version 26.0.Results:40 cases of FAVA patients were admitted during the period, all of whom underwent endoscopic radical resection, including 15 males and 25 females. The age of onset was 8 (6, 12.5) years. The age of diagnosis was 11 (8, 22.5) years. There were 31 patients with stage Ⅰ and 9 patients with stage Ⅱ. 31 cases involved the calf, of which 21 involved the calf triceps (gastrocnemius, soleus) and 9 involved the thigh, of which 1 patient had lesions originating from the fascia around the sciatic neurovascular bundle. 11 cases (27.5%) were converted to open surgery. The operative time was 192.5 (107, 292.5) min. The intraoperative blood loss was 35 (10, 87.5) ml. The length of hospital stay for endoscopic surgery was 9 (7, 11) d. The postoperative follow-up time was 11.5 (3.5, 13.5) months. Of the 40 patients, 39 were cured completely without residual pain or joint movement disorder after operation. Postoperative dorsiflexion function of the ankle joint was mildly limited in one patient classified as stage Ⅱ. There was no incision complication and recurrence.Conclusion:For patients with stage Ⅰ and Ⅱ FAVA, endoscopic surgery has concealed incisions, indistinct scars, definite therapeutic effects and high safety.
